Ro vs Sequence: GLP-1 Programs Compared

Ro and Sequence serve different primary needs. Ro is optimized for patients who want fast, low-friction access to GLP-1 medications at a predictable monthly cash price. Sequence is optimized for patients who want brand-name GLP-1 medications covered by their insurance. Understanding which problem you have determines which platform serves you better.

---

Quick Verdict

	Ro	Sequence
Monthly cost	$149/month (all-in)	~$99/month + medication via insurance
Best for	Fast cash-pay access; tirzepatide	Getting brand-name GLP-1 covered by insurance
Medication	Compounded semaglutide or tirzepatide	Brand-name (Wegovy, Zepbound, Ozempic, Mounjaro)
Insurance navigation	No	Core specialization
Start time	4–7 days	2–4 weeks (insurance process)
Compounded fallback	Yes	Yes (~$149–249/month)

---

The Fundamental Difference

Ro's model: Bypass insurance entirely. Get compounded semaglutide (same active molecule as Wegovy) or tirzepatide at $149/month cash-pay. No insurance paperwork, no prior authorization, no waiting for approval. Fast, predictable, and works for anyone who qualifies medically.

Sequence's model: Use your insurance to pay for brand-name GLP-1 medications. Sequence's clinical team specializes in prior authorization and appeals — the insurance barrier that blocks many patients from brand-name coverage. The program fee (~$99/month) covers the medical oversight and insurance advocacy; the medication cost flows through your insurance plan.

---

When Each Model Wins

Ro wins if:

• Your insurance doesn't cover GLP-1s (or you don't have insurance)
• You want to start in days rather than weeks
• You want tirzepatide (Ro has compounded tirzepatide; Sequence gets you brand-name Zepbound via insurance)
• You want a simple, predictable monthly cost
• You've already tried insurance and it failed

Sequence wins if:

• Your insurance has GLP-1 coverage (or probably does) and you need help getting it approved
• You want brand-name medication (Wegovy, Zepbound) rather than compounded
• You're willing to wait 2–4 weeks for the insurance process to complete
• You've been denied and need an advocate to appeal
• Your net cost with insurance will be lower than $149/month cash-pay

---

Cost Comparison: The Math

Scenario	Ro	Sequence
No insurance coverage	$149/month	$99/month + $149–249 compounded = $248–348/month (Sequence less efficient here)
Insurance covers with low copay ($0–25)	$149/month	$99 + $0–25 copay = $99–124/month (Sequence wins)
Insurance covers with $50 copay	$149/month	$99 + $50 = $149/month (tie)
Insurance covers with $100+ copay	$149/month	$99 + $100+ = $199+/month (Ro wins)
Brand-name vs compounded preference	Compounded at $149	Brand-name via insurance

Bottom line: If your insurance will cover GLP-1s with a copay under $50/month, Sequence likely beats Ro on total cost. If insurance won't cover it or you don't have it, Ro is the cleaner option.

---

Medication: Brand-Name vs Compounded

Aspect	Ro (Compounded)	Sequence (Brand-Name)
Active ingredient	Semaglutide API (same molecule)	FDA-approved Wegovy/Zepbound
FDA approval	No (compounded)	Yes
Manufacturing	503B outsourcing facility	Novo Nordisk / Eli Lilly
Dose flexibility	High	Fixed approved doses
Tirzepatide	Yes (compounded)	Yes (brand Zepbound)
Supply issues	Minimal	Brand-name shortages possible

The compounded vs brand-name question is one of patient preference and insurance situation. Both contain the same active pharmaceutical ingredient for semaglutide. Sequence can also provide compounded medication as a fallback when insurance fails — so you're not locked out if the insurance process doesn't work.

---

Speed to Treatment

Step	Ro	Sequence
Intake and medical evaluation	10–15 minutes	15–20 minutes
Medical review	Same day–24 hours	24–48 hours
Insurance prior auth (if applicable)	N/A	1–3 weeks
Prescription + shipping	3–5 days	3–10 days (after insurance approval)
Total: first dose	~4–7 days	~2–4 weeks

Speed is Ro's clear advantage. If you want to start immediately, Ro is the faster path.

---

Program and Support

Feature	Ro	Sequence
Medical provider access	Async (message-based)	Async + scheduled visits
Insurance advocacy	None	Specialist team
Coaching	Basic provider guidance	Moderate (dietitian access)
Structured program	Minimal	Moderate
Tirzepatide availability	Yes (compounded)	Yes (Zepbound via insurance)

Sequence provides more structured medical management and insurance support. Ro provides faster, simpler access with less overhead.

---

Who Should Choose Which

Choose Ro if:

• You're paying cash and want the lowest-friction path to GLP-1 medication
• You want to start within the week
• Tirzepatide is your preference and you're paying cash
• You want a simple, transparent monthly price with no insurance variables
• You've already tried to get insurance coverage and it failed

Choose Sequence if:

• Your insurance has GLP-1 coverage and you need expert help getting prior authorization
• You want brand-name Wegovy or Zepbound rather than compounded versions
• You're willing to invest 2–4 weeks in the insurance process for lower net monthly cost
• You've been denied and want an experienced team to appeal
• You want ongoing insurance advocacy and management as part of your program

---

Alternatives to Consider

Provider	Why Consider	Monthly Cost
Henry Meds	Fastest start, tirzepatide, $129 after 6 months	$149
FORM Health	Board-certified obesity specialists; insurance navigation	$149+
Calibrate	Insurance navigation + year-long behavioral program	$249 one-time
Noom Med	Behavioral CBT approach + semaglutide at same price	$149

---

Related Resources

• Best GLP-1 Without Insurance — cash-pay options ranked
• Best GLP-1 with Insurance — insurance navigation platforms ranked
• Compounded vs Brand-Name GLP-1 FAQ — safety and efficacy comparison
• GLP-1 Insurance Coverage Guide — how to get GLP-1 covered
• Why Is Ozempic So Expensive — pricing explained